TY - JOUR A1 - Woznicki, Piotr A1 - Laqua, Fabian Christopher A1 - Al-Haj, Adam A1 - Bley, Thorsten A1 - Baeßler, Bettina T1 - Addressing challenges in radiomics research: systematic review and repository of open-access cancer imaging datasets JF - Insights into Imaging N2 - Objectives Open-access cancer imaging datasets have become integral for evaluating novel AI approaches in radiology. However, their use in quantitative analysis with radiomics features presents unique challenges, such as incomplete documentation, low visibility, non-uniform data formats, data inhomogeneity, and complex preprocessing. These issues may cause problems with reproducibility and standardization in radiomics studies. Methods We systematically reviewed imaging datasets with public copyright licenses, published up to March 2023 across four large online cancer imaging archives. We included only datasets with tomographic images (CT, MRI, or PET), segmentations, and clinical annotations, specifically identifying those suitable for radiomics research. Reproducible preprocessing and feature extraction were performed for each dataset to enable their easy reuse. Results We discovered 29 datasets with corresponding segmentations and labels in the form of health outcomes, tumor pathology, staging, imaging-based scores, genetic markers, or repeated imaging. We compiled a repository encompassing 10,354 patients and 49,515 scans. Of the 29 datasets, 15 were licensed under Creative Commons licenses, allowing both non-commercial and commercial usage and redistribution, while others featured custom or restricted licenses. Studies spanned from the early 1990s to 2021, with the majority concluding after 2013. Seven different formats were used for the imaging data. Preprocessing and feature extraction were successfully performed for each dataset. Conclusion RadiomicsHub is a comprehensive public repository with radiomics features derived from a systematic review of public cancer imaging datasets. By converting all datasets to a standardized format and ensuring reproducible and traceable processing, RadiomicsHub addresses key reproducibility and standardization challenges in radiomics. Critical relevance statement This study critically addresses the challenges associated with locating, preprocessing, and extracting quantitative features from open-access datasets, to facilitate more robust and reliable evaluations of radiomics models. Key points - Through a systematic review, we identified 29 cancer imaging datasets suitable for radiomics research. - A public repository with collection overview and radiomics features, encompassing 10,354 patients and 49,515 scans, was compiled. - Most datasets can be shared, used, and built upon freely under a Creative Commons license. - All 29 identified datasets have been converted into a common format to enable reproducible radiomics feature extraction. KW - radiomics KW - radiology KW - cancer imaging KW - machine learning KW - reproducibility of results Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-357936 SN - 1869-4101 VL - 14 ER - TY - JOUR A1 - Vogel, P. A1 - Rückert, M. A. A1 - Greiner, C. A1 - Günther, J. A1 - Reichl, T. A1 - Kampf, T. A1 - Bley, T. A. A1 - Behr, V. C. A1 - Herz, S. T1 - iMPI: portable human-sized magnetic particle imaging scanner for real-time endovascular interventions JF - Scientific Reports N2 - Minimally invasive endovascular interventions have become an important tool for the treatment of cardiovascular diseases such as ischemic heart disease, peripheral artery disease, and stroke. X-ray fluoroscopy and digital subtraction angiography are used to precisely guide these procedures, but they are associated with radiation exposure for patients and clinical staff. Magnetic Particle Imaging (MPI) is an emerging imaging technology using time-varying magnetic fields combined with magnetic nanoparticle tracers for fast and highly sensitive imaging. In recent years, basic experiments have shown that MPI has great potential for cardiovascular applications. However, commercially available MPI scanners were too large and expensive and had a small field of view (FOV) designed for rodents, which limited further translational research. The first human-sized MPI scanner designed specifically for brain imaging showed promising results but had limitations in gradient strength, acquisition time and portability. Here, we present a portable interventional MPI (iMPI) system dedicated for real-time endovascular interventions free of ionizing radiation. It uses a novel field generator approach with a very large FOV and an application-oriented open design enabling hybrid approaches with conventional X-ray-based angiography. The feasibility of a real-time iMPI-guided percutaneous transluminal angioplasty (PTA) is shown in a realistic dynamic human-sized leg model. KW - biomedical engineering KW - electrical and electronic engineering KW - imaging KW - three-dimensional imaging Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-357794 VL - 13 ER - TY - THES A1 - Steingrüber, Marcus T1 - Die perkutane transluminale Zangenbiopsie biliärer Strikturen: Eine neuartige Methode T1 - The percutaneous endobiliary forceps biopsy of biliary strictures: An innovative technique N2 - Das Ziel der Studie bestand darin, die Durchführbarkeit, Effizienz und Sicherheit der perkutanen transluminalen Zangenbiopsie bei biliären Strikturen nach „Cross and push“ Technik am Universitätsklinikum Würzburg zu evaluieren. Die Gewinnung der Zangenbiopsie bei den insgesamt 17 Patienten erfolgte an den baugleichen Angiographieeinheiten der interventionellen radiologischen Abteilung. Die Schaffung des biliären Zugangsweges wurde per Feinnadelpunktion oder über einen bereits einliegenden Drainagekatheter durchgeführt. Nach Vordirigieren einer armierten Führungsschleuse bis unmittelbar vor die Stenose wurden die Gewebeproben mittels Biopsiezange entnommen. Auf diese Weise sollte ein Abknicken des Instrumentariums durch die fibrotische Beschaffenheit der Striktur vermieden und so die Gewebegewinnung erleichtert werden. Im Anschluss folgten die PTCD-Neuanlage bzw. der Katheterwechsel sowie die histologische Auswertung der Zangenbiopsie. Die Dokumentation umfasste den technischen Erfolg, die Biopsieanzahl sowie -größe, die Untersuchungs- und die Fluoroskopiezeit, das Dosisflächenprodukt, die Repräsentativität der Biopsien und die Komplikationsrate. Die technische Erfolgsrate lag bei 100 %. Bei zehn Patienten und Patientinnen (58,8 %) wurde in der Zangenbiopsie ein Malignom bestätigt. Bei sieben Betroffenen (41,2 %) ergab die Zangenbiopsie einen benignen Befund, wobei dieser in zwei Fällen (11,8 %) falsch negativ war. Die Kriterien der Repräsentativität wurden bei elf Patienten und Patientinnen (64,7 %) erfüllt. Die mediane Biopsiezahl betrug 4 und die Biopsiegröße war 1 - 2 mm. Bei einer medianen Untersuchungszeit von 24 min bemaß sich die mediane Fluoroskopiezeit auf 7,6 min. Das mediane DAP für alle Interventionen betrug 2.593 μGym2. Zu einer Majorkomplikation kam es bei einer Patientin (5,9 %). Bei der perkutanen transluminalen Zangenbiopsie nach „Cross and push“ Technik handelt es sich um ein effektives und sicheres Verfahren zur histologischen Beurteilung biliärer Strikturen mit einer moderaten Komplikationsrate. Die Anwendung sollte besonders bei proximalen Strikturen in Betracht gezogen werden, wenn die ERCP oder alternative Verfahren nicht erfolgreich waren und parallel eine Entlastung der Cholestase via PTCD intendiert oder bereits vorhanden ist. Zur weiteren Evaluation der Methode ist zukünftig die Betrachtung eines größeren Patientenkollektives nötig. Um das Verfahren mit Alternativmethoden vergleichen zu können, bedarf es randomisierter kontrollierter Studien. N2 - Percutaneous transhepatic biliary drainage-based forceps biopsy in patients with biliary obstruction of unknown origin is an relatively unknown procedure. Nonetheless this method offers the opportunity of tissue sampling and therapy of obstructive jaundice via percutaneous transhepatic biliary drainage (PTBD) simultaneously. In 2015 Patel et al. described the percutaneous endobiliary forceps biopsy (PEFB) using “cross and push” technique. This approach is characterized by using a guiding sheath to push and advance the biopsy forceps into the biliary stricture. By supporting the forceps biopsy catheter with a sheath, a retroflexion of the forceps cup leading to an ineffective biopsy can be prevented. Aim of the following study was to evaluate feasibility, efficiency and safety of this procedure in our institution. Between October 2014 and October 2019 17 patients underwent PEFB in the interventional radiology department. Biliary access was achieved by using a percutaneous access needle or via a preexisting external biliary drainage catheter. After obtaining the specimens for histopathologic evaluation, a new biliary drainage catheter was placed. The primary outcome measures were: evaluation of technical success rate, procedure time and fluoroscopy time, dose area product (DAP), complication rate, number and size of the biopsies as well as the histopathologic results. Technical success rate was 100 %. In ten patients PEFB confirmed a malignant biliary stricture. Seven patients had a benign histopathologic result, although in two cases this proofed to be false negative. In eleven patients the tissue samples proofed to be representative for the underlying disease. The median number of biopsies was 4 with a size between 1 -2 mm. The median procedure time was 24 minutes with a median fluoroscopy time of 7,6 minutes. Median DAP was 2.593 μGym2. Complications occurred in three cases with one major complication and minor complications in two patients. The percutaneous endobiliary forceps biopsy is a feasible and safe technique for histologic evaluation of biliary strictures. The procedure should be considered in cases not allowing an endoscopic approach and when the drainage of obstructive jaundice via PTBD is planned or already present. KW - Zangenbiopsie KW - biliäre Striktur KW - biliäre Stenose KW - Gallengangsstenose KW - PEFB Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-321721 ER - TY - JOUR A1 - Schreiber, Laura M. A1 - Lohr, David A1 - Baltes, Steffen A1 - Vogel, Ulrich A1 - Elabyad, Ibrahim A. A1 - Bille, Maya A1 - Reiter, Theresa A1 - Kosmala, Aleksander A1 - Gassenmaier, Tobias A1 - Stefanescu, Maria R. A1 - Kollmann, Alena A1 - Aures, Julia A1 - Schnitter, Florian A1 - Pali, Mihaela A1 - Ueda, Yuichiro A1 - Williams, Tatiana A1 - Christa, Martin A1 - Hofmann, Ulrich A1 - Bauer, Wolfgang A1 - Gerull, Brenda A1 - Zernecke, Alma A1 - Ergün, Süleyman A1 - Terekhov, Maxim T1 - Ultra-high field cardiac MRI in large animals and humans for translational cardiovascular research JF - Frontiers in Cardiovascular Medicine N2 - A key step in translational cardiovascular research is the use of large animal models to better understand normal and abnormal physiology, to test drugs or interventions, or to perform studies which would be considered unethical in human subjects. Ultrahigh field magnetic resonance imaging (UHF-MRI) at 7 T field strength is becoming increasingly available for imaging of the heart and, when compared to clinically established field strengths, promises better image quality and image information content, more precise functional analysis, potentially new image contrasts, and as all in-vivo imaging techniques, a reduction of the number of animals per study because of the possibility to scan every animal repeatedly. We present here a solution to the dual use problem of whole-body UHF-MRI systems, which are typically installed in clinical environments, to both UHF-MRI in large animals and humans. Moreover, we provide evidence that in such a research infrastructure UHF-MRI, and ideally combined with a standard small-bore UHF-MRI system, can contribute to a variety of spatial scales in translational cardiovascular research: from cardiac organoids, Zebra fish and rodent hearts to large animal models such as pigs and humans. We present pilot data from serial CINE, late gadolinium enhancement, and susceptibility weighted UHF-MRI in a myocardial infarction model over eight weeks. In 14 pigs which were delivered from a breeding facility in a national SARS-CoV-2 hotspot, we found no infection in the incoming pigs. Human scanning using CINE and phase contrast flow measurements provided good image quality of the left and right ventricle. Agreement of functional analysis between CINE and phase contrast MRI was excellent. MRI in arrested hearts or excised vascular tissue for MRI-based histologic imaging, structural imaging of myofiber and vascular smooth muscle cell architecture using high-resolution diffusion tensor imaging, and UHF-MRI for monitoring free radicals as a surrogate for MRI of reactive oxygen species in studies of oxidative stress are demonstrated. We conclude that UHF-MRI has the potential to become an important precision imaging modality in translational cardiovascular research. KW - ultrahigh-field MRI KW - large animal models KW - translational research KW - research infrastructure KW - heart KW - organoid KW - pig KW - cardiovascular MRI Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-317398 SN - 2297-055X VL - 10 ER - TY - THES A1 - Portmann, Johannes T1 - Accelerated inversion recovery MRI of the myocardium using spiral acquisition T1 - Beschleunigte Inversion-Recovery MR-Bildgebung des Myokards mit spiralen Auslesezügen N2 - This work deals with the acceleration of cardiovascular MRI for the assessment of functional information in steady-state contrast and for viability assessment during the inversion recovery of the magnetization. Two approaches are introduced and discussed in detail. MOCO-MAP uses an exponential model to recover dynamic image data, IR-CRISPI, with its low-rank plus sparse reconstruction, is related to compressed sensing. MOCO-MAP is a successor to model-based acceleration of parametermapping (MAP) for the application in the myocardial region. To this end, it was augmented with a motion correction (MOCO) step to allow exponential fitting the signal of a still object in temporal direction. Iteratively, this introduction of prior physical knowledge together with the enforcement of consistency with the measured data can be used to reconstruct an image series from distinctly shorter sampling time than the standard exam (< 3 s opposed to about 10 s). Results show feasibility of the method as well as detectability of delayed enhancement in the myocardium, but also significant discrepancies when imaging cardiac function and artifacts caused already by minor inaccuracy of the motion correction. IR-CRISPI was developed from CRISPI, which is a real-time protocol specifically designed for functional evaluation of image data in steady-state contrast. With a reconstruction based on the separate calculation of low-rank and sparse part, it employs a softer constraint than the strict exponential model, which was possible due to sufficient temporal sampling density via spiral acquisition. The low-rank plus sparse reconstruction is fit for the use on dynamic and on inversion recovery data. Thus, motion correction is rendered unnecessary with it. IR-CRISPI was equipped with noise suppression via spatial wavelet filtering. A study comprising 10 patients with cardiac disease show medical applicability. A comparison with performed traditional reference exams offer insight into diagnostic benefits. Especially regarding patients with difficulty to hold their breath, the real-time manner of the IR-CRISPI acquisition provides a valuable alternative and an increase in robustness. In conclusion, especially with IR-CRISPI in free breathing, a major acceleration of the cardiovascular MR exam could be realized. In an acquisition of less than 100 s, it not only includes the information of two traditional protocols (cine and LGE), which take up more than 9.6 min, but also allows adjustment of TI in retrospect and yields lower artifact level with similar image quality. N2 - Diese Arbeit behandelt die Beschleunigung der kardiovaskulären MRT zum Erfassen funktioneller Information bei Steady-State-Kontrast und zur Unter- suchung der Vitalität bei Wiederherstellung der Magnetisierung nach ihrer Inversion. Zwei Ansätze werden eingeführt und im Detail diskutiert: MOCO- MAP, welches ein exponentielles Modell nutzt, um dynamische Daten zu rekonstruieren, und IR-CRISPI, welches mit seinem “low-rank plus sparse"- Algorithmus mit Compressed Sensing verwandt ist. MOCO-MAP ist der Nachfolger der modellbasierten Beschleunigung des Parameter-Mappings (MAP) für die Anwendung im Bereich des Myokards. Hierzu wurde es mit einer Bewegungskorrektur (MOCO) versehen, um expo- nentielles Fitten eines unbewegten Objects in Zeitrichtung zu ermöglichen. Das Einbringen dieses physikalischen Vorwissens zusammen mit dem Erzwin- gen von Konsistenz mit den Messdaten wird dazu genutzt, iterativ eine Bildfolge aus Daten einer deutlich kürzeren Messung als herkömmlich zu rekonstruieren (< 3 s gegenüber ca. 10 s). Die Ergebnisse zeigen die Umsetz- barkeit der Methode sowie die Nachweisbarkeit von Delayed Enhancements im Myokard, aber deutliche funktionelle Abweichungen und Artefakte bereits aufgrund von kleinen Ungenauigkeiten der Bewegungskorrektur. IR-CRISPI geht aus CRISPI hervor, welches zur Auswertung von funk- tionellen Echtzeitdaten bei konstantem Kontrast dient. Mit der Rekon- struktion durch getrennte Berechnung von niedrigrangigem und dünnbe- setztem Matrixanteil wird hier bei der Datenrekonstruktion weniger stark eingeschränkt als bei einem strikten exponentiellen Modell. Die pirale Auf- nahmeweise erlaubt hierzu ausreichend effiziente k-Raumabdeckung. Die “low-rank plus sparse"-Rekonstruktion ist kompatibel mit dynamischen und mit Inversion-Recovery-Daten. Eine Bewegungskorrektur ist folglich nicht nötig. IR-CRISPI wurde mit einer Rauschunterdrückung durch räumliche Wavelet- Filterung versehen. Eine Studie, die 10 Patienten einschließt, zeigt die Eignung für die medizinische Anwendung. Der Vergleich mit herkömm- lichen Aufnahmetechniken lässt auf den gewonnenen diagnostischen Nutzen schließen. Besonders für Patienten, die Schwierigkeiten mit dem Luftanhal- ten haben, eröffnet diese Echtzeitaufnahmemethode eine wertvolle Alterna- tive und erhöhte Stabilität. Am Ende konnte gerade mittels IR-CRISPI eine bemerkenswerte Beschleu- nigung der kardiovaskulären MR-Untersuchung verwirklicht werden. Trotz der kurzen Aufnahmezeit von weniger als 100 s für den kompletten linken Ven- trikel schließt es nicht nur die Information zweier herkömmlicher Protokolle mit ein (Cine und LGE), die zusammen mehr als 9,6 min dauern, sondern es erlaubt zusätzlich auch das Einstellen der TI-Zeit im Nachhinein und liefert Ergebnisse mit geringerem Artefaktlevel bei ähnlicher Bildqualität KW - Kernspintomografie KW - Herzfunktion KW - Herzmuskel KW - Bildgebendes Verfahren KW - Echtzeit KW - cine loop KW - late enhancement KW - late gadolinium-enhancement KW - magnetic resonance imaging KW - real-time imaging KW - spiral trajectory Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-302822 ER - TY - JOUR A1 - Patzer, Theresa Sophie A1 - Kunz, Andreas Steven A1 - Huflage, Henner A1 - Luetkens, Karsten Sebastian A1 - Conrads, Nora A1 - Gruschwitz, Philipp A1 - Pannenbecker, Pauline A1 - Ergün, Süleyman A1 - Bley, Thorsten Alexander A1 - Grunz, Jan-Peter T1 - Quantitative and qualitative image quality assessment in shoulder examinations with a first-generation photon-counting detector CT JF - Scientific Reports N2 - Photon-counting detector (PCD) CT allows for ultra-high-resolution (UHR) examinations of the shoulder without requiring an additional post-patient comb filter to narrow the detector aperture. This study was designed to compare the PCD performance with a high-end energy-integrating detector (EID) CT. Sixteen cadaveric shoulders were examined with both scanners using dose-matched 120 kVp acquisition protocols (low-dose/full-dose: CTDI\(_{vol}\) = 5.0/10.0 mGy). Specimens were scanned in UHR mode with the PCD-CT, whereas EID-CT examinations were conducted in accordance with the clinical standard as “non-UHR”. Reconstruction of EID data employed the sharpest kernel available for standard-resolution scans (ρ\(_{50}\) = 12.3 lp/cm), while PCD data were reconstructed with both a comparable kernel (11.8 lp/cm) and a sharper dedicated bone kernel (16.5 lp/cm). Six radiologists with 2–9 years of experience in musculoskeletal imaging rated image quality subjectively. Interrater agreement was analyzed by calculation of the intraclass correlation coefficient in a two-way random effects model. Quantitative analyses comprised noise recording and calculating signal-to-noise ratios based on attenuation measurements in bone and soft tissue. Subjective image quality was higher in UHR-PCD-CT than in EID-CT and non-UHR-PCD-CT datasets (all p < 0.001). While low-dose UHR-PCD-CT was considered superior to full-dose non-UHR studies on either scanner (all p < 0.001), ratings of low-dose non-UHR-PCD-CT and full-dose EID-CT examinations did not differ (p > 0.99). Interrater reliability was moderate, indicated by a single measures intraclass correlation coefficient of 0.66 (95% confidence interval: 0.58–0.73; p < 0.001). Image noise was lowest and signal-to-noise ratios were highest in non-UHR-PCD-CT reconstructions at either dose level (p < 0.001). This investigation demonstrates that superior depiction of trabecular microstructure and considerable denoising can be realized without additional radiation dose by employing a PCD for shoulder CT imaging. Allowing for UHR scans without dose penalty, PCD-CT appears as a promising alternative to EID-CT for shoulder trauma assessment in clinical routine. KW - bone KW - musculoskeletal system Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-357925 VL - 13 ER - TY - JOUR A1 - Patzer, Theresa Sophie A1 - Kunz, Andreas Steven A1 - Huflage, Henner A1 - Conrads, Nora A1 - Luetkens, Karsten Sebastian A1 - Pannenbecker, Pauline A1 - Paul, Mila Marie A1 - Ergün, Süleyman A1 - Bley, Thorsten Alexander A1 - Grunz, Jan-Peter T1 - Ultrahigh-resolution photon-counting CT in cadaveric fracture models: spatial frequency is not everything JF - Diagnostics N2 - In this study, the impact of reconstruction sharpness on the visualization of the appendicular skeleton in ultrahigh-resolution (UHR) photon-counting detector (PCD) CT was investigated. Sixteen cadaveric extremities (eight fractured) were examined with a standardized 120 kVp scan protocol (CTDI\(_{vol}\) 10 mGy). Images were reconstructed with the sharpest non-UHR kernel (Br76) and all available UHR kernels (Br80 to Br96). Seven radiologists evaluated image quality and fracture assessability. Interrater agreement was assessed with the intraclass correlation coefficient. For quantitative comparisons, signal-to-noise-ratios (SNRs) were calculated. Subjective image quality was best for Br84 (median 1, interquartile range 1–3; p ≤ 0.003). Regarding fracture assessability, no significant difference was ascertained between Br76, Br80 and Br84 (p > 0.999), with inferior ratings for all sharper kernels (p < 0.001). Interrater agreement for image quality (0.795, 0.732–0.848; p < 0.001) and fracture assessability (0.880; 0.842–0.911; p < 0.001) was good. SNR was highest for Br76 (3.4, 3.0–3.9) with no significant difference to Br80 and Br84 (p > 0.999). Br76 and Br80 produced higher SNRs than all kernels sharper than Br84 (p ≤ 0.026). In conclusion, PCD-CT reconstructions with a moderate UHR kernel offer superior image quality for visualizing the appendicular skeleton. Fracture assessability benefits from sharp non-UHR and moderate UHR kernels, while ultra-sharp reconstructions incur augmented image noise. KW - photon-counting KW - tomography KW - X-ray computed KW - fracture KW - cancellous bone KW - convolution kernel Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-319281 SN - 2075-4418 VL - 13 IS - 10 ER - TY - JOUR A1 - Luetkens, Karsten Sebastian A1 - Grunz, Jan-Peter A1 - Kunz, Andreas Steven A1 - Huflage, Henner A1 - Weißenberger, Manuel A1 - Hartung, Viktor A1 - Patzer, Theresa Sophie A1 - Gruschwitz, Philipp A1 - Ergün, Süleyman A1 - Bley, Thorsten Alexander A1 - Feldle, Philipp T1 - Ultra-high-resolution photon-counting detector CT arthrography of the ankle: a feasibility study JF - Diagnostics N2 - This study was designed to investigate the image quality of ultra-high-resolution ankle arthrography employing a photon-counting detector CT. Bilateral arthrograms were acquired in four cadaveric specimens with full-dose (10 mGy) and low-dose (3 mGy) scan protocols. Three convolution kernels with different spatial frequencies were utilized for image reconstruction (ρ\(_{50}\); Br98: 39.0, Br84: 22.6, Br76: 16.5 lp/cm). Seven radiologists subjectively assessed the image quality regarding the depiction of bone, hyaline cartilage, and ligaments. An additional quantitative assessment comprised the measurement of noise and the computation of contrast-to-noise ratios (CNR). While an optimal depiction of bone tissue was achieved with the ultra-sharp Br98 kernel (S ≤ 0.043), the visualization of cartilage improved with lower modulation transfer functions at each dose level (p ≤ 0.014). The interrater reliability ranged from good to excellent for all assessed tissues (intraclass correlation coefficient ≥ 0.805). The noise levels in subcutaneous fat decreased with reduced spatial frequency (p < 0.001). Notably, the low-dose Br76 matched the CNR of the full-dose Br84 (p 0.999) and superseded Br98 (p < 0.001) in all tissues. Based on the reported results, a photon-counting detector CT arthrography of the ankle with an ultra-high-resolution collimation offers stellar image quality and tissue assessability, improving the evaluation of miniscule anatomical structures. While bone depiction was superior in combination with an ultra-sharp convolution kernel, soft tissue evaluation benefited from employing a lower spatial frequency. KW - photon-counting CT KW - arthrography KW - ankle KW - cartilage KW - radiation dosage Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-362622 SN - 2075-4418 VL - 13 IS - 13 ER - TY - THES A1 - Lucius, Leonie Johanna T1 - Die endovaskuläre Therapie der malignen unteren Einflussstauung mit dem Sinus-XL® Stent T1 - Endovascular therapy of malignant obstruction of the inferior vena cava with the Sinus-XL® stent system N2 - Die interventionelle Radiologie hat sich in den letzten Jahrzehnten zunehmend auf palliativmedizinische sowie onkologische Bereiche ausgeweitet und kann durch minimal-invasive Therapieoptionen gerade in vulnerablen Patientenkollektiven attraktive Behandlungsmöglichkeiten zur Verfügung stellen. Die tumorbedingte untere Einflussstauung ist ein seltenes Krankheitsbild und stellt eine schwere symptomatische Komplikation einer malignen Grunderkrankung dar. Dabei kommt es im Rahmen dieser Grunderkrankung durch die Primärtumormasse oder Metastasen zu extrinsischer Kompression der Vena cava inferior (VCI), Gefäßinvasion oder Thrombusbildung. Ziel der Dissertationsarbeit ist es, den technischen und klinischen Erfolg der Sinus-XL ® Stentimplantation in die Vena cava inferior bei einer tumorbedingten unteren Einflussstauung zu untersuchen. Als technischer Erfolg wurde dabei die problemlose Stentimplantation mit anschließender Aufhebung der VCI-Stenose/Okklusion und Revaskularisation der VCI definiert. Bezüglich des klinischen Erfolges wurde der Frage nachgegangen, inwieweit die Stentimplantation die typischen Symptome einer unteren Einflussstauung (Ödeme der unteren Extremität, Aszites und Anasarka) lindern und bestenfalls eliminieren kann. In der vorliegenden Arbeit sind dazu retrospektiv die Daten von insgesamt 21 Patienten (11 Frauen, 10 Männer) mit einem medianen Alter von 61 Jahren (19-92 Jahre), die zwischen Oktober 2010 und Januar 2021 aufgrund einer tumorbedingten unteren Einflussstauung mit einem Sinus-XL ® Stent endovaskulär versorgt wurden, ausgewertet worden. Zur Quantifizierung der klinischen Symptomatik wurde für das jeweilige Symptom ein Scoring-System entwickelt bzw. modifiziert. Der technische Erfolg belief sich auf 100% (21/21). Postinterventionell konnte zudem eine signifikante Reduktion des transstenotischen Druckgradienten (p = 0,008) und eine signifikante Aufweitung des Stenosendiameters (p < 0,001) erreicht werden. Die primäre und primär-assistierte Stentoffenheit betrug 92,9 % (13/14) und 100% (14/14), die anatomische Stentoffenheit (< 50% Restenose) belief sich auf 53,3 % (8/15). Die Reinterventionsrate lag bei 4,8 % (1/21). Schwerwiegende Komplikationen traten nicht auf. Der klinische Erfolg bezüglich der Ödeme der unteren Extremität belief sich auf 82,4 % (14/17), 93,8 % (15/16) sowie auf 85,7 % (18/21) und zeigte in allen betrachteten Zeitintervallen eine signifikante Scorewertreduktion (p < 0,001). Das klinische Outcome bezüglich der Ödeme war bei kürzeren Stenosen/Obstruktionen signifikant besser (p = 0,025). Bezüglich einer intrahepatischen Segmentbeteiligung, der transstenotischen Druckgradienten, der absoluten Gradientenreduktion sowie der Überlebenszeit nach der Intervention zeigten sich hingegen keine als klinisch relevant einzustufende Ergebnisse. Ein eindeutiger Effekt der Intervention auf die Symptome Anasarka und Aszites konnte nicht nachgewiesen werden. Diesbezüglich zeigten sich klinische Erfolgsraten von 42,9 % (6/14) und 5,3 % (1/19). Im postinterventionellen Verlauf konnten außerdem signifikante Reduktionen der präinterventionellen Harnstoffwerte sowie des Körpergewichtes der Patienten verzeichnet werden. Zusammenfassend zeigt die vorliegende Arbeit, dass die Sinus-XL ® Stentimplantation geeignet ist, eine tumorbedingte Vena cava inferior-Stenose/Obstruktion aufzuheben und eine Revaskularisation der VCI zu erreichen. Die klinischen Symptome einer unteren Einflussstauung – insbesondere bezogen auf die Ödeme der unteren Extremität und mit Einschränkungen bezogen auf die Symptome Aszites und Anasarka – können ebenfalls durch die Stentimplantation gelindert und teilweise sogar langanhaltend eliminiert werden. Die Sinus-XL ® Stentimplantation sollte daher stets als Therapieoption bei tumorbedingten unteren Einflussstauungen in Erwägung gezogen werden. Nicht zuletzt stellt die Stentimplantation auch eine sichere und komplikationsarme Intervention dar. Weitere Studien, bestenfalls multizentrische Studien, sind jedoch notwendig, um die dargestellten Ergebnisse weiter zu untermauern. N2 - In recent decades interventional radiology has increasingly expanded into palliative as well as oncologic settings and can provide attractive treatment options through minimal-invasive therapies, especially in vulnerable patient populations. Malignant obstruction of the inferior vena cava (IVC) is a rare clinical condition and represents a severe symptomatic complication of an underlying malignant disease. Extrinsic compression of the inferior vena cava, vascular invasion or thrombus formation occur as part of the underlying disease. The aim of this work is to investigate the technical and clinical success of Sinus-XL ® stent implantation into the inferior vena cava in case of malignant obstruction of the inferior vena cava. Technical success was defined as the successful stent implantation with subsequent resolution of the stenosis/occlusion and revascularization of the IVC. Regarding clinical success, the question was addressed to what extent stent implantation can alleviate and, at best, eliminate the typical symptoms of malignant IVC obstruction (lower extremity edema, ascites and anasarca). Therefore data from a total of 21 patients (11 women, 10 men) with a median age of 61 years (19-92 years) who underwent endovascular treatment with a Sinus-XL ® stent for malignant IVC obstruction between October 2010 and January 2021 was retrospectively analyzed. In order to quantify the extent of the clinical symptoms a scoring system was developed or modified for each symptom. The technical success was 100% (21/21). After the intervention a significant reduction of the transstenotic pressure gradient (p = 0.008) and a significant widening of the stenotic diameter (p < 0.001) were achieved. Primary and primary-assisted stent patency were 92.9% (13/14) and 100% (14/14), anatomic stent patency (< 50% restenosis) was 53.3% (8/15). The reintervention rate was 4.8% (1/21). No major complications occurred. The clinical outcome regarding lower extremity edema was 82.4% (14/17), 93.8% (15/16), and 85.7% (18/21), showing a significant score reduction in all time intervals considered (p < 0.001). Clinical outcome regarding edema was significantly better with shorter stenosis/obstruction (p = 0.025). In contrast, with regard to intrahepatic segment involvement, transstenotic pressure gradients, absolute gradient reduction, and survival time after the intervention, there were no results that could be classified as clinically relevant. A clear effect of the intervention on the symptoms of anasarca and ascites could not be demonstrated. In this regard, clinical success rates of 42.9% (6/14) and 5.3% (1/19) were shown. In the post-interventional course, significant reductions of the pre-interventional urea levels as well as of the patients´ body weight could also be recorded. In conclusion, the present work shows that Sinus-XL ® stent implantation is suitable to resolve malignant IVC obstruction and to achieve revascularization of the IVC. The clinical symptoms - especially related to lower extremity edema and with limitations related to the symptoms of ascites and anasarca - can be alleviated by stent implantation and in some cases even eliminated. Sinus-XL ® stent implantation should therefore always be considered as a therapeutic option for malignant IVC obstruction. Last but not least, stent implantation also represents a safe and low-complication intervention. However, further studies, at best multicenter studies, are necessary to further substantiate the presented results. KW - Vena cava inferior KW - Stent KW - Interventionsradiologie KW - Onkologie KW - maligne untere Einflussstauung KW - endovaskuläre Therapie Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-326691 ER - TY - JOUR A1 - Laqua, Fabian Christopher A1 - Woznicki, Piotr A1 - Bley, Thorsten A. A1 - Schöneck, Mirjam A1 - Rinneburger, Miriam A1 - Weisthoff, Mathilda A1 - Schmidt, Matthias A1 - Persigehl, Thorsten A1 - Iuga, Andra-Iza A1 - Baeßler, Bettina T1 - Transfer-learning deep radiomics and hand-crafted radiomics for classifying lymph nodes from contrast-enhanced computed tomography in lung cancer JF - Cancers N2 - Objectives: Positron emission tomography (PET) is currently considered the non-invasive reference standard for lymph node (N-)staging in lung cancer. However, not all patients can undergo this diagnostic procedure due to high costs, limited availability, and additional radiation exposure. The purpose of this study was to predict the PET result from traditional contrast-enhanced computed tomography (CT) and to test different feature extraction strategies. Methods: In this study, 100 lung cancer patients underwent a contrast-enhanced \(^{18}\)F-fluorodeoxyglucose (FDG) PET/CT scan between August 2012 and December 2019. We trained machine learning models to predict FDG uptake in the subsequent PET scan. Model inputs were composed of (i) traditional “hand-crafted” radiomics features from the segmented lymph nodes, (ii) deep features derived from a pretrained EfficientNet-CNN, and (iii) a hybrid approach combining (i) and (ii). Results: In total, 2734 lymph nodes [555 (20.3%) PET-positive] from 100 patients [49% female; mean age 65, SD: 14] with lung cancer (60% adenocarcinoma, 21% plate epithelial carcinoma, 8% small-cell lung cancer) were included in this study. The area under the receiver operating characteristic curve (AUC) ranged from 0.79 to 0.87, and the scaled Brier score (SBS) ranged from 16 to 36%. The random forest model (iii) yielded the best results [AUC 0.871 (0.865–0.878), SBS 35.8 (34.2–37.2)] and had significantly higher model performance than both approaches alone (AUC: p < 0.001, z = 8.8 and z = 22.4; SBS: p < 0.001, z = 11.4 and z = 26.6, against (i) and (ii), respectively). Conclusion: Both traditional radiomics features and transfer-learning deep radiomics features provide relevant and complementary information for non-invasive N-staging in lung cancer. KW - computed tomography KW - computational neural networks KW - lymphatic metastasis KW - carcinoma KW - non-small-cell lung KW - small-cell lung Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-319231 SN - 2072-6694 VL - 15 IS - 10 ER -